| Previous Close | 0.4 |
| Open | 0.4 |
| Day High | 0.41 |
| Day Low | 0.37 |
| 52-Week High | 6.23 |
| 52-Week Low | 0.28 |
| Volume | 866,379 |
| Average Volume | 7.55M |
| Market Cap | 4.02M |
| PE | -0.27 |
| EPS | -1.42 |
| Moving Average 50 Days | 0.65 |
| Moving Average 200 Days | 1.27 |
| Change | -0.01 |
Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad
GlobeNewswire Inc.
Dec 05, 2025 1:30 PM GMT
NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) -- via BioMedWire: — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by BioMedWire ("BMW"), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwor
Soligenix Inc. (NASDAQ: SNGX) Proprietary Platform Aims to Meet Growing Need for Effective CTCL Therapy
GlobeNewswire Inc.
Aug 07, 2025 12:30 PM GMT
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrand
Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space
GlobeNewswire Inc.
Aug 05, 2025 12:30 PM GMT
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrand